Welcome to our dedicated page for FULLER H B CO SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
H.B. Fuller Company filings document formal disclosures for a Minnesota-based public company that manufactures and sells adhesives, sealants and chemical-based products. Current reports furnish quarterly and fiscal-year operating results, including revenue, margin, adjusted EBITDA and guidance disclosures tied to pricing, raw-material costs, restructuring savings and acquisition or divestiture effects.
Proxy and governance filings cover annual meeting matters, director elections, auditor ratification, advisory executive-compensation votes, board committee service and director compensation arrangements. The filing record also includes exhibits and Inline XBRL cover data associated with material-event reports.
Form S-8 Filing Overview: H.B. Fuller Company (NYSE: FUL) filed a Form S-8 on 26 June 2025 to register additional shares for its equity compensation program.
Shares Registered: The filing covers (1) 2,000,000 new common shares authorized under the Third Amended and Restated 2020 Master Incentive Plan, approved by shareholders on 15 April 2025, and (2) up to 128,907 shares recycled from previously forfeited or cancelled awards under the 2018 and 2020 plans. All shares carry a $1.00 par value.
Purpose & Mechanics: Form S-8 enables immediate issuance of stock or option awards to employees, officers and directors. The filing automatically incorporates the company’s latest 10-K (FY-2024), 10-Qs (Q1 & Q2 FY-2025) and specified 8-Ks by reference, ensuring continual updating of material information without separate prospectus supplements.
Corporate & Legal Context: H.B. Fuller is a Large Accelerated Filer incorporated in Minnesota. Indemnification provisions follow Section 521 of the Minnesota Business Corporation Act. The company maintains D&O liability insurance, and Articles/Bylaws limit director monetary liability to the fullest extent permitted by state law.
Potential Investor Implications: • The newly registered shares represent incremental equity capacity for employee incentives, supporting talent retention and alignment. • The maximum dilution impact equals roughly 4 % of FUL’s ~53 million shares outstanding (based on latest 10-K), though actual dilution depends on grant timing and vesting. • No proceeds accrue to the company at registration; any cash inflow arises only if options with exercise prices are exercised.
H.B. Fuller (NYSE:FUL) filed its Q2 2025 Quarterly Report (10-Q) for the period ended May 31 2025.
The XBRL detail indicates:
- Common shares outstanding: 53.95 M, down from 54.66 M, reflecting ongoing buybacks.
- Accounts payable: $160 M.
- Amended Term Loan B: $300 M bearing SOFR/Prime-based rates; interest expense disclosed.
- Restructuring: employee severance and other costs recorded through 5/31/25.
- Disposal of the North America flooring business treated as a non-discontinued sale.
- Active interest-rate swaps and net-investment hedges remain in place.
Results are reported across three segments—Hygiene, Engineering, and Building Adhesive Solutions—plus corporate unallocated items. No new guidance or dividend changes were noted.
H.B. Fuller (NYSE:FUL) filed a Form 8-K on June 26, 2025, furnishing its second-quarter 2025 earnings press release (Exhibit 99.1) under Item 2.02.
No financial figures are included in the 8-K body; the company simply incorporates the press release by reference and states the information is furnished, not filed, limiting liability under Section 18.
The filing lists standard Exhibit 104 iXBRL cover-page data and bears the signature of Senior Vice President and General Counsel Gregory O. Ogunsanya.
H.B. Fuller Executive VP and CFO John J. Corkrean reported changes in beneficial ownership on June 20, 2025. Key details include:
The insider acquired 172.73 Phantom Units at $54.57 per unit, which convert to common stock on a 1:1 basis. Following this transaction, Corkrean holds 52,196 shares of common stock directly.
- Maintains significant stock option positions across various strike prices ($43.48-$77.72) and expiration dates (2026-2035)
- Holds multiple Restricted Stock Unit (RSU) grants totaling 8,457.96 units vesting in three annual installments
- Currently owns 25,562.4 Phantom Units including dividend equivalents
The transaction was executed under regular reporting requirements, with most options being fully vested, while newer grants from 2024-2026 follow a 33%-33%-34% vesting schedule.